阅读说明：本技术 用于负压伤口治疗系统的冗余控件 (Redundant controls for negative pressure wound therapy systems ) 是由 费利克斯·克拉伦斯·昆塔纳 于 2018-05-04 设计创作，主要内容包括：本发明公开了负压伤口治疗系统和方法的实施例。在一个实施例中,系统包括伤口敷料、负压源、开关和控制电路。开关可包括致动器,所述致动器响应于用户输入而切换第一对触点的状态和第二对触点的状态。当第一对触点的状态是第一状态且第二对触点的状态是第二状态时,控制电路可用负压源供应负压；当第一对触点的状态不是第一状态或第二对触点的状态不是第二状态时,控制电路可以禁止用负压源供应负压。(Embodiments of negative pressure wound therapy systems and methods are disclosed. In one embodiment, a system includes a wound dressing, a negative pressure source, a switch, and a control circuit. The switch may include an actuator that switches the state of the first pair of contacts and the state of the second pair of contacts in response to a user input. The control circuit may supply a negative pressure with the negative pressure source when the state of the first pair of contacts is a first state and the state of the second pair of contacts is a second state; the control circuit may inhibit the supply of negative pressure with the negative pressure source when the state of the first pair of contacts is not the first state or the state of the second pair of contacts is not the second state.)

1. An apparatus for applying negative pressure to a wound, the apparatus comprising:

a negative pressure source configured to provide negative pressure to a wound dressing through a fluid flow path;

a switch comprising an actuator configured to switch a state of a first pair of electrical contacts and a state of a second pair of electrical contacts in response to a user input; and

a control circuit configured to:

supplying a negative pressure with the negative pressure source in response to the first pair of electrical contacts being in an electrically connected state and the second pair of electrical contacts being in an electrically connected state, and

disabling the supply of negative pressure with the negative pressure source in response to the first pair of electrical contacts being in an electrically open state or the second pair of electrical contacts being in an electrically open state.

2. The apparatus of claim 1, wherein the control circuit is configured to inhibit supply of negative pressure with the negative pressure source in response to the first pair of electrical contacts being in the electrically connected state and the second pair of electrical contacts being in an electrically disconnected state.

3. The device of claim 1 or claim 2, wherein the actuator is configured to simultaneously switch the state of the first pair of electrical contacts and the state of the second pair of electrical contacts in response to the user input.

4. The apparatus of any one or more of claims 1-3, wherein the control circuitry is configured to supply negative pressure with the negative pressure source in response to no user input other than user input to the switch.

5. The apparatus of any one or more of claims 1-4, wherein when the actuator is damaged and is no longer able to switch the state of the first pair of electrical contacts or the state of the second pair of electrical contacts, the control circuitry is further configured to no longer supply negative pressure with the negative pressure source.

6. The device of any one or more of claims 1-5, wherein the control circuit is further configured to detect a switch failure in response to the state of the first pair of electrical contacts not switching within a threshold period of time after the state of the second pair of electrical contacts switching.

7. The apparatus of claim 6, wherein the threshold period of time is 0.5 seconds, 1 second, 2 seconds, 3 seconds, or 5 seconds.

8. The apparatus of claim 6 or claim 7, wherein the control circuit is further configured to output a switch failure indication in response to detecting the switch failure.

9. The device of any one or more of claims 1-8, wherein the first pair of electrical contacts comprises a first plurality of traces and the second pair of electrical contacts comprises a second plurality of traces, and the actuator is configured to short the first plurality of traces to each other and the second plurality of traces to each other in response to the user input.

10. The apparatus of any one or more of claims 1-9, wherein the negative pressure source is disposed on or within the wound dressing.

11. The apparatus of any one or more of claims 1-10, wherein the control circuitry is configured to inhibit supply of negative pressure with the negative pressure source by: deactivating operation of the negative pressure source, opening a vent located in the fluid flow path, or closing a valve located in the fluid flow path.

12. The device of any one or more of claims 1-11, wherein the switch is configured to receive user input as a press of the switch.

13. A method for controlling the application of negative pressure to a wound, the method comprising:

switching a state of a first pair of contacts and a state of a second pair of contacts using an actuator of a switch in response to receiving a user input to the switch;

responsive to the state of the first pair of contacts being a first state and the state of the second pair of contacts being a second state, supplying negative pressure to the wound dressing through the fluid flow path with a source of negative pressure; and

in response to the state of the first pair of contacts not being the first state or the state of the second pair of contacts not being the second state, inhibiting the supply of negative pressure with the negative pressure source,

wherein at a first time the state of the first pair of contacts is the first state and the state of the second pair of contacts is the second state, and at a second time the state of the first pair of contacts is not the first state and the state of the second pair of contacts is not the second state.

14. The method of claim 13, wherein the first state and the second state correspond to forming an electrical connection.

15. The method of claim 13 or claim 14, wherein at a third time, the state of the first pair of contacts is the first state and the state of the second pair of contacts is not the second state.

16. The method of any one or more of claims 13-15, wherein the switching comprises simultaneously switching the state of the first pair of contacts and the state of the second pair of contacts in response to receiving a user input to the switch.

17. The method of any one or more of claims 13-16, further comprising detecting a switch failure in response to the state of the first pair of contacts not switching within a threshold period of time after the state of the second pair of contacts switching.

18. The method of claim 17, wherein the threshold time period is between 0.5 seconds and 5 seconds.

19. The method of claim 17 or claim 18, further comprising outputting a switch failure indication for presentation to a user in response to the detecting.

20. The method of any one or more of claims 13-19, wherein the inhibiting comprises inhibiting the supply of negative pressure with the negative pressure source by: deactivating operation of the negative pressure source, opening a vent located in the fluid flow path, or closing a valve located in the fluid flow path.

Background

Embodiments of the present disclosure relate to methods and apparatus for dressing and treating wounds with negative or reduced pressure therapy or Topical Negative Pressure (TNP) therapy. In particular, but not by way of limitation, embodiments disclosed herein relate to negative pressure therapy devices, methods for controlling the operation of TNP systems, and methods of using TNP systems.

Disclosure of Invention

In some embodiments, an apparatus for applying negative pressure to a wound is disclosed. The apparatus may comprise: a negative pressure source configured to provide negative pressure to a wound dressing through a fluid flow path; a switch comprising an actuator configured to switch a state of a first pair of electrical contacts and a state of a second pair of electrical contacts in response to a user input; and control circuitry configured to: supplying negative pressure with the negative pressure source in response to the first pair of electrical contacts being in an electrically connected state and the second pair of electrical contacts being in an electrically connected state, and inhibiting supply of negative pressure with the negative pressure source in response to the first pair of electrical contacts being in an electrically disconnected state or the second pair of electrical contacts being in an electrically disconnected state.

The apparatus described in the preceding paragraph may include one or more of the following features: the control circuit is configured to inhibit supply of negative pressure with the negative pressure source in response to the first pair of electrical contacts being in the electrically connected state and the second pair of electrical contacts being in the electrically disconnected state. The actuator is configured to simultaneously switch the state of the first pair of electrical contacts and the state of the second pair of electrical contacts in response to the user input. The control circuit is configured to supply negative pressure with the negative pressure source in response to no user input other than user input to the switch. When the actuator is damaged and is no longer able to switch the state of the first pair of electrical contacts or the state of the second pair of electrical contacts, the control circuit is further configured to no longer supply negative pressure with the negative pressure source. The control circuit is further configured to detect a switch failure in response to the state of the first pair of electrical contacts not switching within a threshold period of time after the state of the second pair of electrical contacts switches. The threshold time period is 0.5 seconds, 1 second, 2 seconds, 3 seconds, or 5 seconds. The control circuit is further configured to output a switch failure indication in response to detecting a switch failure. The first pair of electrical contacts includes a first plurality of traces and the second pair of electrical contacts includes a second plurality of traces, and the actuator is configured to short the first plurality of traces to each other and the second plurality of traces to each other in response to the user input. The negative pressure source is disposed on or within the wound dressing. The control circuit is configured to inhibit supply of negative pressure with the negative pressure source by: deactivating operation of the negative pressure source, opening a vent located in the fluid flow path, or closing a valve located in the fluid flow path. The switch is configured to receive the user input as a depression of the switch.

In some embodiments, a method for controlling the application of negative pressure to a wound is disclosed. The method comprises the following steps: switching a state of a first pair of contacts and a state of a second pair of contacts using an actuator of a switch in response to receiving a user input to the switch; supplying negative pressure to the wound dressing through the fluid flow path with a source of negative pressure in response to the state of the first pair of contacts being a first state and the state of the second pair of contacts being a second state; and in response to the state of the first pair of contacts not being the first state or the state of the second pair of contacts not being the second state, inhibiting the supply of negative pressure with the negative pressure source; wherein at a first time the state of the first pair of contacts is the first state and the state of the second pair of contacts is the second state, and at a second time the state of the first pair of contacts is not the first state and the state of the second pair of contacts is not the second state.

The method of the previous paragraph may include one or more of the following features: the first state and the second state correspond to the formation of an electrical connection. At a third time, the state of the first pair of contacts is the first state and the state of the second pair of contacts is not the second state. The switching includes simultaneously switching a state of the first pair of contacts and a state of the second pair of contacts in response to receiving a user input to the switch. The method also includes detecting a switch failure in response to the state of the first pair of contacts not switching within a threshold period of time after the state of the second pair of contacts switches. The threshold time period is between 0.5 seconds and 5 seconds. The method also includes outputting a switch failure indication for presentation to a user in response to the detecting. The inhibiting includes inhibiting the supply of negative pressure with the negative pressure source by: deactivating operation of the negative pressure source, opening a vent located in the fluid flow path, or closing a valve located in the fluid flow path.

Drawings

The features and advantages of the present disclosure will become apparent from the following detailed description considered in conjunction with the accompanying drawings, in which:

fig. 1 illustrates a negative pressure therapy system according to some embodiments.

Fig. 2A and 2B illustrate side and top views, respectively, of a negative pressure therapy system (e.g., the negative pressure therapy system of fig. 1) according to some embodiments.

Fig. 3A illustrates a circuit schematic of a negative pressure therapy system (e.g., the negative pressure therapy system of fig. 1) according to some embodiments.

Fig. 3B is a logic truth table of the circuit schematic of fig. 3A according to some embodiments.

Fig. 4A, 4B, 5A, 5B, 6A, and 6B illustrate implementations of the circuit schematic of fig. 3A according to some embodiments.

Fig. 7 illustrates a therapy control process that may be used to control negative pressure therapy delivery in a negative pressure therapy system (e.g., the negative pressure therapy system of fig. 1), according to some embodiments.

Fig. 8 illustrates a switch failure detection process that may be used to detect a switch failure in a negative pressure therapy system (e.g., the negative pressure therapy system of fig. 1), according to some embodiments.

Detailed Description

The present disclosure relates to methods and apparatus for dressing and treating wounds with reduced pressure therapy or Topical Negative Pressure (TNP) therapy. In particular, but not by way of limitation, embodiments of the present disclosure relate to negative pressure therapy devices, methods for controlling the operation of TNP systems, and methods of using TNP systems. The methods and apparatus may include or implement any combination of the features described below. In certain embodiments, the features of the present disclosure may advantageously improve patient safety when using a TNP device.

Many different types of wound dressings are known for aiding the healing process in humans or animals. These different types of wound dressings include many different types of materials and layers, for example, gauze, pads, foam pads, or multi-layer wound dressings. TNP therapy, sometimes referred to as vacuum assisted closure, negative pressure wound therapy or reduced pressure wound therapy, may be a beneficial mechanism for promoting the rate of healing of a wound. This therapy is applicable to a wide range of wounds, such as incisions, open wounds, abdominal wounds, and the like.

TNP therapy may help to close and heal wounds by: reduction of tissue edema; promoting blood flow; stimulating the formation of granulation tissue; removal of excess exudate, and reduction of bacterial load and hence wound infection. Moreover, TNP therapy may allow the wound to be less externally disturbed, promoting more rapid healing.

As used herein, a reduced or negative pressure level (such as, -X mmHg) represents a sub-atmospheric pressure level, which typically corresponds to 760mmHg (or 1atm, 29.93inHg, 101.325kPa, 14.696psi, etc.). Thus, a negative pressure value of-XmmHg reflects a pressure lower than atmospheric pressure X mmHg, for example, a pressure of (760-X) mmHg. Further, a negative pressure "less" or "less" than-X mmHg corresponds to a pressure closer to atmospheric pressure (e.g., -40 mmHg is less than-60 mmHg). A negative pressure "more" or "greater" than-XmmHg corresponds to a pressure further away from atmospheric pressure (e.g., -80 mmHg is greater than-60 mmHg).

Overview

The user interface of some TNP devices may have limited elements through which a user may provide user input. In some cases, a particular user interface may include only a single element that is available to the user to stop and start operation of the TNP device (such as negative pressure delivery), and the user may not be able to replace or swap the functionality of that single element with that of another element. These particular user interfaces may ideally be easier to construct and operate than more complex user interfaces having many elements. However, certain user interfaces may become problematic when a single element experiences a failure (e.g., a failure) and is no longer able to function as intended. For example, if negative pressure is being provided by the TNP device, a user of a particular user interface may not be able to pause or stop negative pressure delivery, which is undesirable.

Situations where the user is unable to stop negative pressure delivery may additionally pose a risk to the wound healing or health of the patient. If the patient feels uncomfortable with the wound dressing during negative pressure delivery and the individual elements fail to be operable to receive user input, the patient may be forced to continue applying negative pressure therapy despite the danger, or to remove the wound dressing, cut or sever one of the tubes or lumens (which may not be possible when a source of negative pressure is integrated into the wound dressing), destroy the TNP device (e.g., by pulling out electronics (as may), remove a power source (as accessible), etc., to terminate the delivery of negative pressure. These actions (e.g., removal of the wound dressing) can damage the patient's wound and hinder any healing trajectory that has already been in progress, as well as expose the wound to external contaminants due to loss of protection of the wound dressing.

To help prevent situations where a user is unable to stop delivery of negative pressure when it is necessary to stop the delivery of negative pressure, a TNP device having a single element that is available to the user to stop and start delivery of negative pressure may include redundant activation or deactivation controls or mechanisms within the single element. In one example, the single element may be a switch including an actuator configured to switch a state of the first pair of contacts and a state of the second pair of contacts. Causing the TNP device to inhibit delivery of the negative pressure therapy if the state of one or both of the first pair of contacts or the second pair of contacts is switched during delivery of the negative pressure therapy. Thus, in the event that the actuator may be damaged and only one of the first and second pairs of contacts can be switched, the actuator may still be used to stop the delivery of negative pressure with the TNP device.

Reduced pressure treatment systems and methods

Fig. 1 illustrates a negative pressure therapy system 100 including a TNP device 11 and a wound 14. The TNP device 11 may be used to treat a wound 14. The TNP device 11 may include a control circuit 12A, a memory 12B, a negative pressure source 12C, a user interface 12D, a power source 12E, a first pressure sensor 12F, a second pressure sensor 12G (which may be optional), and a skin detector 12H, all configured to be in electrical communication with each other. Additionally, the TNP device 11 may include a wound dressing 13. The power supply 12E may provide power to one or more components of the TNP device 11.

One or more of the control circuit 12A, memory device 12B, negative pressure source 12C, user interface 12D, power source 12E, first pressure sensor 12F, second pressure sensor 12G, and skin detector 12H may be integrated with, incorporated as part of, attached to, or disposed in the wound dressing 13. The TNP device 11 may therefore be considered to have its control electronics and pumps on the wound dressing 13, rather than being separate from the wound dressing 13.

The control circuit 12A may include one or more of a controller, an activation circuit, a boost converter, a current limiter, a feedback conditioning circuit, and an H-bridge inverter. The one or more controllers may control the operation of one or more other components of the TNP device 11 in accordance with at least the instructions stored in the memory means 12B. The one or more controllers may control operation of negative pressure source 12C, for example, through signal input (e.g., pulse width modulation of signals) of one or more H-bridge inverters, which in turn drive power from power source 12E to negative pressure source 12C.

Negative pressure source 12C may include a pump such as, but not limited to, a rotary diaphragm pump or other diaphragm pump, a piezoelectric pump, a peristaltic pump, a piston pump, a rotary vane pump, a liquid ring pump, a vortex pump, a pump operated by a piezoelectric transducer, a voice coil pump, or any other suitable pump or micropump or any combination of the foregoing.

User interface 12D may include one or more elements that receive user input or provide user output to a patient or caregiver. The one or more elements that receive user input may include buttons, switches, dials, touch screens, etc., and the one or more elements that provide user output may include activation of a Light Emitting Diode (LED) or one or more pixels of a display or activation of a speaker, etc. In one example, the user interface 12D may include a switch that receives a first user input (e.g., a negative pressure activation or deactivation input) and two LEDs that indicate an operational status of the TNP device 11 (e.g., working properly, in a fault state, or waiting for a user input).

The first pressure sensor 12F may be used to monitor the pressure under the wound dressing 13, for example, the pressure in the fluid flow path connecting the negative pressure source 12C and the wound 14, the pressure at the wound 14, or the pressure in the negative pressure source 12C. A second pressure sensor 12G may be used to monitor the pressure outside the wound dressing 13. The pressure outside the wound dressing may be atmospheric pressure; however, the atmospheric pressure may vary depending on, for example, the altitude at which it is used or the pressurization environment in which the TNP device 11 may be used.

The control circuit 12A may control the negative pressure supply of the negative pressure source 12C based on a comparison between at least the pressure monitored by the first pressure sensor 12F and the pressure monitored by the second pressure sensor 12G. The control circuit 12A may include a controller, such as a microcontroller or microprocessor.

Skin detector 12H may be used to determine whether wound dressing 13 has been placed over wound 14. The skin detector 12H may, for example, detect the skin of the patient. Detection by skin detector 12H may confirm whether wound dressing 13 is coupled to the patient's skin proximate wound 14. When skin is detected, this may indicate that the activation of the TNP device 11 is intentional and not unintentional, and may therefore be used to prevent unintentional activation of the TNP device 11 or an end-of-life timer of the TNP device 11, for example during transportation or manufacture of the TNP device 11. In one example, if the skin detector 12H indicates to the control circuit 12A that skin is detected, the control circuit 12A may activate the negative pressure source 12C to supply negative pressure in response to receiving an activation input via the user interface 12D. If, on the other hand, the skin detector 12H indicates to the control circuit 12A that no skin is detected, the control circuit 12A may not activate the negative pressure source 12C to supply negative pressure in response to receiving an activation input via the user interface 12D. Skin detector 12H may include one or more of a capacitive sensor, an impedance sensor, an optical sensor, a piezoresistive sensor, a piezoelectric sensor, an elastic resistive sensor, and an electrochemical sensor.

Wound dressing 13 may include a wound contact layer, a spacer layer, and an absorbent layer. The wound contact layer may be in contact with the wound 14. The wound contact layer may include an adhesive on the patient facing side for securing the dressing to the skin surrounding the wound 14; or include an adhesive on the top side for securing the wound contact layer to a cover layer or other layer of the wound dressing 13. In operation, the wound contact layer may provide unidirectional flow to facilitate removal of exudate from the wound while blocking or substantially preventing exudate from returning to the wound 14. The spacer layer may help distribute negative pressure over the wound site and help facilitate the transport of wound exudates and fluids into the wound dressing 13. In addition, the absorbent layer may absorb and retain exudates drawn from the wound 14.

In some cases, the control circuit 12A may prevent negative pressure from being supplied with the negative pressure source 12C. For example, the control circuit 12A may prevent the supply of negative pressure by disabling operation of the negative pressure source, opening a vent located in the fluid flow path, and closing a valve located in the fluid flow path.

In some cases, the supply of negative pressure with negative pressure source 12C may be prohibited. For example, the supply of negative pressure may be inhibited by deactivating the operation of the negative pressure source 12C or the control circuit 12A, opening a vent located in the fluid flow path, and closing a valve located in the fluid flow path. In some embodiments, deactivating the negative pressure source 12C or the control circuit 12A may be performed by disconnecting power to the negative pressure source 12C or the control circuit 12A or withdrawing an activation signal provided to the negative pressure source 12C or the control circuit 12A.

The control circuit 12A may monitor the duty cycle of the negative pressure source 12C. As used herein, a "duty cycle" may reflect the amount of time that the negative pressure source 12C is active or running over a period of time. In other words, the duty cycle may reflect the time that the negative pressure source 12C is active as part of the total time under consideration. The duty cycle measurement may reflect the activity level of the negative pressure source 12C. For example, the duty cycle may indicate that the negative pressure source 12C is functioning properly, is working hard, is working extremely hard, and so on. Moreover, the duty cycle measurements, e.g., the periodic duty cycle measurements, may reflect various operating conditions, such as the presence or severity of leaks, the fluid flow rate (e.g., air, liquid, or solid exudate) aspirated from the wound, and so forth. Based on the duty cycle measurement, the controller may execute or be programmed to execute an algorithm or logic that controls the operation of the system, for example by comparing the measured duty cycle to a set of thresholds (e.g., determined in calibration). For example, the duty cycle measurement may indicate the presence of a high leak, and the control circuit 12A may be programmed to indicate this status to a user (e.g., a patient, caregiver, or physician) or to temporarily interrupt or suspend operation of the negative pressure source in order to conserve power.

When the TNP device 11 may be used to treat a wound 14, the wound dressing 13 may create a substantially sealed or enclosed space around the wound 13 and beneath the wound dressing 13 in which the first pressure sensor 12F may periodically or continuously measure or monitor the pressure level. The control circuit 12A can control the pressure level in this space between a first negative pressure set point limit and at least a second negative pressure set point limit. In some cases, the first set point limit may be approximately-70 mmHg, or from approximately-60 mmHg or less to approximately-80 mmHg or more. In some cases, the second set point limit may be approximately-90 mmHg, or from approximately-80 mmHg or less to approximately-100 mmHg or more.

Fig. 2A illustrates a side view of the negative pressure therapy system 200, and fig. 2B illustrates a top view of the negative pressure therapy system 200. The negative pressure therapy system 200 may be an example embodiment of the negative pressure therapy system 100.

In the negative pressure therapy system 200, the wound dressing 13 of the TNP device 11 is shown attached to the wound 14. The arrows depict the flow of air through the wound dressing 13 and wound exudate from the wound 14. The TNP device 11 may include an exhaust gas 26 and a component area 25, such as a component housing or storage area for components of the TNP device 11 (e.g., one or more of the control circuit 12A, the memory device 12B, the negative pressure source 12C, the user interface 12D, the power source 12E, the first pressure sensor 12F, the second pressure sensor 12G, and the skin sensor 12H).

The user interface 12D of the negative pressure therapy system 200 may include a switch 21, a first indicator 23 (e.g., a first LED), and a second indicator 24 (e.g., a second LED). The switch 21 may receive a negative pressure activation or deactivation user input (e.g., in response to pressing the switch 21, receiving an activation or deactivation user input). The first indicator 23 and the second indicator 24 may indicate an operational state such as working properly, being in a fault state or waiting for user input. In some embodiments, the switch 21 may be coupled to a power connection of the negative pressure source 12C or the control circuit 12A (e.g., a controller of the control circuit 12A) or an enable signal of the negative pressure source 12C or the control circuit 12A to activate or deactivate the negative pressure supply or to disable the negative pressure supply. Further, the control circuit 12A may monitor the user interface 12D, e.g., the switch 21, the first indicator 23 or the second indicator 24, to detect problems like faults, and in response to the fault detection, output a fault indication via the user interface 12D, or activate or deactivate the negative pressure supply or disable the negative pressure supply. In certain embodiments, the control circuit 12A may supply negative pressure with the negative pressure source 12C in response to no user input other than the user input of the switch 21.

The component parts of the wound dressing 13 of the negative pressure therapy system 200 are illustrated as including an air lock layer 27, an absorbent layer 28, and a contact layer 29. The air lock layer 27 can make air flow. The absorbent layer 28 may absorb wound exudate. The contact layer 29 may be soft and comprise silicon and is used to couple the TNP device 11 to the patient.

Fig. 3A illustrates a circuit schematic 300 for a switch similar to switch 21, in accordance with some embodiments. The switch may be a double pole, single throw switch and include an actuator that switches the state of multiple sets of contacts (e.g., two, three, four, or more sets of contacts) in response to a user input (e.g., depression of the switch). The actuator may switch the state of multiple sets of contacts simultaneously or in a staggered manner. As shown in fig. 3A, the plurality of sets of contacts includes: a first pair of contacts including contacts 302, 304 (which together with the first contact pad form a first switch, which may be referred to as SW 1); and a second pair of contacts including contacts 306, 308 (which together with the first contact pad form a second switch, which may be referred to as SW 2). SW1 and SW2 may act as redundant switches. Although the schematic diagram 300 illustrates two pairs of contacts, any of the switches described herein may include more than two pairs of contacts.

The contacts 302, 304 are shown open and the contacts 306, 308 are shown open. The contacts 302, 304 may be open because the contact pads of SW1 do not electrically connect or short the contacts 302, 304 together. SW1 may also be considered open when contacts 302, 304 are open. Similarly, the contacts 306, 308 may be open because the contact pads of SW2 do not electrically connect or short the contacts 306, 308 together. SW2 may also be considered open when contacts 306, 308 are open.

The contacts 302, 304 may be closed when the contact pads of SW1 electrically connect or short the contacts 302, 304 together. SW1 may also be considered closed when closing contacts 302, 304. The contacts 306, 308 may be closed when the contact pads of SW2 electrically connect or short the contacts 306, 308 together. SW2 may also be considered closed when contacts 306, 308 are closed.

The switch may also include an input a and an output B. For example, the input a may be electrically coupled to a power source (e.g., power source 12E) or ground of the TNP device 11, and the output B may be electrically coupled to control operation of the TNP device (or vice versa). When the switch is closed, an electrical connection is made to the power or ground, thereby enabling the TNP device 11 to operate or function to provide therapy. For example, when the switch is closed, a signal may be provided or generated to the control circuit 12A to activate the negative pressure source 12C, or to enable power to be supplied to other components of the TNP device 11 by the power source 12E.

In some embodiments, the state of the sets of contacts may be switched only in response to user input to the switch when the switch is operating normally. However, if the switch is damaged and the actuator is no longer able to switch one or more of the sets of contacts, the switch may no longer switch the state of all of the sets of contacts in response to user input. Thus, if the actuator is no longer able to switch one or more of the sets of contacts, the control circuit 12A may no longer be configured to supply negative pressure with the negative pressure source 12C.

Fig. 3B is a logic truth table 310 of the circuit schematic 300. It can be appreciated from logic truth table 310 that if both SW1 and SW2 are closed, the electrical path from input A to output B can be considered to be formed or "on" and if at least one of SW1 or SW2 is open, the electrical path from input A to output B can be considered to be not formed or "off".

In other embodiments, the switches may be designed differently than circuit schematic 300 and function according to an alternative logic truth table different from logic truth table 310. An alternative logic truth table may include a number of possible configurations, and each configuration turns an electrical path from input a to output B on or off. One or more of a plurality of possible configurations of the alternative logic truth table may turn on an electrical path from input a to output B, and one or more other configurations of the plurality of configurations of the alternative logic truth table may turn off an electrical path from input a to output B. In some embodiments, the total number of the plurality of configurations that turn on the electrical path from input a to output B may be less than the total number of the plurality of configurations that turn off the electrical path from input a to output B. This may advantageously result in a bias towards breaking the electrical path from input a to output B unless the switch is operating properly. As a result, the switch may intelligently cause the negative pressure source 12C to operate when the switch is operating normally and not when the switch is not operating normally.

Fig. 4A and 4B illustrate an implementation of a circuit schematic 300 according to some embodiments. Contacts 402, 404, 406, 408 may be an implementation of contacts 302, 304, 306, 308, respectively. Contact pad 410 of SW1 may be an embodiment of the contact pad of SW1 of fig. 3A, and contact pad 412 of SW2 may be an embodiment of the contact pad of SW2 of fig. 3A.

As shown, at least some of the contacts 402, 404, 406, 408 may each include a primary trace and a plurality of secondary traces extending from the primary trace. The plurality of secondary traces may each extend perpendicular to the primary trace from which the secondary trace extends. The primary traces may be curved relative to the contacts 402, 408 as shown, or straight relative to the contacts 404, 406 as shown. For example, the primary and secondary traces of the contacts 402, 404, 406, 408 may be printed on a circuit board.

In fig. 4A, the contacts 402, 404 are shown open and the contacts 406, 408 are shown open. In fig. 4B, contacts 402, 404 are shown closed because contact pad 410 of SW1 is in contact with contacts 402, 404, and contacts 406 and 408 are shown closed because contact pad 412 of SW2 is in contact with contacts 406, 408. For example, an electrical path is formed from input a to output B through contact 402, contact pad 410, contact 404, contact 406, contact pad 412, and contact 408. Contact pad 410 of SW1 and contact pad 412 of SW2 may be conductive plates. The contact pads 410, 412 may make contact with the contacts 402, 404, 406, 408 through an actuator (or actuators) that may be actuated by a user input (e.g., depression of a switch), mechanically, pneumatically, electrically, etc.

Fig. 5A and 5B illustrate another implementation of a circuit schematic 300 according to some embodiments. Contacts 502, 504, 506, 508 may be an implementation of contacts 302, 304, 306, 308, respectively. Contact pad 510 of SW1 may be an embodiment of the contact pad of SW1 of fig. 3A, and contact pad 512 of SW2 may be an embodiment of the contact pad of SW2 of fig. 3A.

As shown, at least some of the contacts 502, 504, 506, 508 may each include a primary trace and a plurality of secondary traces extending from the primary trace. The plurality of secondary traces may each extend perpendicular to the primary trace from which the secondary trace extends. The primary trace may be straight as shown. For example, the primary and secondary traces of the contacts 502, 504, 506, 508 may be printed on a circuit board.

In fig. 5A, the contacts 502, 504 are shown open and the contacts 506, 508 are shown open. In fig. 5B, the contacts 502, 504 are shown closed because the contact pad 510 of SW1 is in contact with the contacts 502, 504, and the contacts 506 and 508 are shown closed because the contact pad 512 of SW2 is in contact with the contacts 506, 508. For example, an electrical path is formed from input a to output B through contact 502, contact pad 510, contact 504, contact 506, contact pad 512, and contact 508. Contact pad 510 of SW1 and contact pad 512 of SW2 may be conductive plates. The contact pads 510, 512 may make contact with the contacts 502, 504, 506, 508 through an actuator (or actuators) that may be actuated by a user input (e.g., depression of a switch), mechanically, pneumatically, electrically, etc.

Fig. 6A and 6B illustrate another implementation of a circuit schematic 300 according to some embodiments. Contacts 502, 604, 606, 608 may be an implementation of contacts 302, 304, 306, 308, respectively. Contact pad 610 of SW1 may be an embodiment of the contact pad of SW1 of fig. 3A, and contact pad 612 of SW2 may be an embodiment of the contact pad of SW2 of fig. 3A.

As shown, at least some of the contacts 602, 604, 606, 608 may each include a perimeter trace extending around the conductive region. For example, the peripheral traces and contact areas of the contacts 602, 604, 606, 608 may be printed on a circuit board.

In fig. 6A, the contacts 602, 604 are shown open and the contacts 606, 608 are shown open. In fig. 6B, contacts 602, 604 are shown closed because contact pad 610 of SW1 is in contact with contacts 602, 604, and contacts 606 and 608 are shown closed because contact pad 612 of SW2 is in contact with contacts 606, 608. For example, an electrical path is formed from input a to output B through contact 602, contact pad 610, contact 604, contact 606, contact pad 612, and contact 608. Contact pad 610 of SW1 and contact pad 612 of SW2 may be conductive plates. The contact pads 610, 612 may make contact with the contacts 602, 604, 606, 608 through an actuator (or actuators) that may be actuated by a user input (e.g., depression of a switch), mechanically, pneumatically, electrically, etc.

Fig. 7 illustrates a therapy control process 700 that may be used to control the delivery of negative pressure therapy by a device (e.g., the TNP device 11). For convenience, the therapy control process 700 is described in the context of the TNP device 11, but may alternatively be implemented in other systems described herein or by other systems not shown. In some cases, the therapy control process 700 may be performed by the control circuit 12A alone or in conjunction with the user interface 12D of the TNP device 11.

At block 702, the therapy control process 700 may receive user input. For example, user input may be received via user interface 12D, such as by depressing switch 21.

At block 704, the therapy control process 700 may attempt to switch the state of multiple sets of contacts (e.g., close contacts) in response to user input. For example, the switch 21 may include an actuator (or actuators) that may attempt to switch the state of pairs of contacts like contacts 302, 304 and contacts 306, 308. The switch 21 can switch the state of the pairs of contacts if the switch 21 is operating normally. For example, the states of the pairs of contacts may each be switched simultaneously (or substantially simultaneously) or one by one, thereby closing each of the pairs of contacts. The switch 21 may not switch the state of one or more of the pairs of contacts if the switch 21 is not operating properly.

At block 706, if the states of the sets of contacts are not switched, the therapy control process 700 may end. On the other hand, if the states of the multiple sets of contacts are switched, the therapy control process 700 may move to block 708 to supply negative pressure. The supply of negative pressure may be initiated by the control circuit 12A and performed by the negative pressure source 12C, and negative pressure may be supplied to the wound dressing 13 via the fluid flow path.

At block 710, if the state of the sets of contacts remain unchanged, the therapy control process 700 may again move to block 708 and the supply of negative pressure may continue. On the other hand, at block 710, if the state of at least one of the sets of contacts changes (e.g., opens), the therapy control process 700 may move to block 712. For example, user input may be received through user interface 12D, such as by depressing switch 21, and may cause the state of one or more of the pairs of contacts to switch. The switch 21 can switch the state of the pairs of contacts if the switch 21 is operating normally. For example, the states of the pairs of contacts may each be switched simultaneously (or substantially simultaneously) or one by one, thereby opening each of the pairs of contacts. The switch 21 may not switch the state of one or more of the pairs of contacts if the switch 21 is not operating properly.

At block 712, the therapy control process 700 may disable the supply of negative pressure. The supply of negative pressure may be disabled, for example, by disabling operation of the negative pressure source 12C or the control circuit 12A, opening a vent located in the fluid flow path, and closing a valve located in the fluid flow path. Because switching fewer than all of the multiple sets of contacts (e.g., open) at block 710 may cause the therapy control process 700 to move from block 710 to block 712, in certain embodiments, the therapy control process 700 may advantageously support or favor inhibiting negative pressure supply in response to some indication of inhibiting negative pressure supply despite not receiving an expected indication that may involve switching all of the multiple sets of contacts. After block 712, the therapy control process 700 may end. In some embodiments, block 710 may be performed periodically or in response to a change in the state of one or more contacts (e.g., due to an interrupt generated when the state of one or more contacts is switched). In some embodiments, block 710 may be performed while supplying negative pressure.

Fig. 8 illustrates a switch failure detection process 800 that may be used to detect a switch failure in a device configured to deliver negative pressure wound therapy, such as the TNP device 11. For convenience, the switch failure detection process 800 is described in the context of the TNP device 11, but may alternatively be implemented in other systems described herein or by other systems not shown. For example, the switch failure detection process 800 may be performed by the control circuit 12A alone or in combination with the user interface 12D. Process 800 may be used to detect a fault in user interface 12D. In some cases, the switch failure detection process 800 may begin with the negative pressure source 12C turned off and no negative pressure is provided.

At block 802, the switch fault detection process 800 may detect a state switch of one contact in a set of contacts. For example, control circuit 12A may detect a switch in state of one of a pair of contacts of switch 21, such as contacts 302, 304 shown in fig. 3A. For example, this switching may be detected from a change in an electrical characteristic (e.g., voltage or current), a mechanical characteristic, a pressure characteristic, or a thermal characteristic of one of a pair of contacts of the switch 21, and may be detected using a sensor.

At block 804, the switch fault detection process 800 may determine whether the state of another set of contacts is switched. For example, control circuit 12A may detect a state switch of the other contact of a pair of contacts of switch 21 (e.g., contacts 306, 308 shown in fig. 3A) in response to a user input to switch 21. For example, this switching may be detected from a change in an electrical characteristic (e.g., voltage or current), a mechanical characteristic, a pressure characteristic, or a thermal characteristic of the other of the pair of contacts of the switch 21, and may be detected using a sensor.

If the state of another set of contacts is toggled, the switch fault detection process 800 may move to block 806 and supply negative pressure. The supply of negative pressure may be initiated by the control circuit 12A and performed by the negative pressure source 12C, and negative pressure may be supplied to the wound dressing 13 via the fluid flow path.

If the state of another set of contacts has not been toggled, the switch fault detection process 800 may move to block 808 and output a switch fault indication. Failure of the other set of contacts to switch may indicate that the other set of contacts failed to switch as expected by the user input. For example, control circuit 12A detects a switch failure from another set of unswitched contacts and outputs a switch failure indication accordingly, e.g., for presentation on user interface 12D. At block 804, the switch failure detection process 800 may additionally monitor switching of another set of contacts for a period of time (e.g., 0.5 seconds, 1 second, 2 seconds, 3 seconds, 5 seconds, or more) before moving to block 808 and outputting a switch failure indication.

Although the processes in fig. 7 and 8 describe switching one or more contacts to enable or disable the supply of negative pressure, switching one or more contacts may be used to control other functions of the TNP device 11, such as the initial activation of the TNP device 11.

Other variants

Although one of many examples in this disclosure describes that the negative pressure source, control circuitry, or other components may be part of an integrated unit, such as an on-board wound dressing, the example or examples do not limit the scope of this disclosure to this integrated unit. For example, features relating to redundant activation or deactivation control may be included as part of the TNP device, which is not integral with, or separate from, the wound dressing or any medical or electronic device.

Any values of thresholds, limits, durations, etc. provided herein are not intended to be absolute, and thus may be approximate. Further, any thresholds, limits, durations, etc. provided herein may be fixed or changed automatically or by a user. Further, relative terms such as exceeding, greater than, less than, etc., relative to a reference value, as used herein, are intended to also encompass being equal to the reference value. For example, exceeding a positive reference value may include being equal to or greater than the reference value. Further, relative terms such as above, greater than, less than, and the like, as used herein with respect to a reference value, are also intended to encompass the inverse of the disclosed relationship, such as below, less than, greater than, and the like, with respect to the reference value. Further, while blocks of various processes may be described in terms of determining whether a value meets or does not meet a particular threshold, these blocks may be similarly understood, e.g., in terms of values (i) that are below or above the threshold or (ii) that meet or do not meet the threshold.

Features, materials, characteristics, or groups described in connection with a particular aspect, embodiment, or example are understood to apply to any other aspect, embodiment, or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features or steps are mutually exclusive. The protection is not restricted to the details of any of the foregoing embodiments. Any novel feature or any novel combination of features disclosed in this specification (including any accompanying claims, abstract and drawings), or any novel feature or any novel combination of steps of any method or process so disclosed, is claimed.

While certain embodiments have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of protection. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms. Furthermore, various omissions, substitutions and changes in the form of the methods and systems described herein may be made. Those of skill in the art will understand that in some embodiments, the actual steps taken in the processes shown or disclosed may differ from those shown in the figures. According to embodiments, some of the steps described above may be eliminated, and other steps may be added. For example, the actual steps or sequence of steps taken in the disclosed processes may differ from those shown in the figures. According to embodiments, some of the steps described above may be eliminated, and other steps may be added. For example, the various components shown in the figures may be implemented as software or firmware on a processor, controller, ASIC, FPGA, or dedicated hardware. Hardware components such as processors, ASICs, FPGAs, etc. may comprise logic circuitry. Furthermore, the features and attributes of the specific embodiments disclosed above may be combined in different ways to form additional embodiments, all of which fall within the scope of the present disclosure.

The user interface screens illustrated and described herein may include additional or alternative components. These components may include menus, lists, buttons, text boxes, tabs, radio buttons, scroll bars, slide bars, check boxes, combo boxes, status bars, dialog boxes, windows, and the like. The user interface screen may include additional or alternative information. The components may be arranged, grouped, displayed in any suitable order.

While the present disclosure includes certain embodiments, examples, and applications, it will be understood by those skilled in the art that the present disclosure extends beyond the specifically disclosed embodiments to other alternative embodiments or uses and obvious modifications and equivalents thereof, including embodiments that do not provide all of the features and advantages described herein. Accordingly, the scope of the present disclosure is not intended to be limited by the specific disclosure of the preferred embodiments herein, and may be defined by the claims set forth herein or by claims set forth in the future.

Conditional language, such as "can," "might," or "may," unless expressly stated otherwise or understood otherwise in the context of usage, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain functions, elements, or steps. Thus, such conditional language is not generally intended to imply that features, elements, or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without user input or prompting, whether these features, elements, or steps are included or are to be performed in any particular embodiment. The terms "comprising," "including," "having," and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and the like. Furthermore, the term "or" is used in its inclusive sense (and not in its exclusive sense) so that, when used, e.g., to connect a list of elements, the term "or" means one, some, or all of the elements in the list. Further, the term "each" as used herein may mean any subset of a set of elements to which the term "each" applies, except having its ordinary meaning.

Joint language such as the phrase "X, Y and at least one of Z" is understood in this context to mean that items, terms, etc. may be X, Y or Z in general, unless explicitly stated otherwise. Thus, such conjunctive language is not meant to imply that certain embodiments require the presence of at least one of X, at least one of Y, and at least one of Z in general.

The terms "about," "approximately," "substantially," and "approximately" as used herein mean a value, amount, or characteristic that is close to a stated value, amount, or characteristic, that still performs the desired function or achieves the desired result. For example, the terms "about," "substantially," and "substantially" may refer to an amount within less than 10%, within less than 5%, within less than 1%, within less than 0.1%, and within less than 0.01% of the specified amount. As another example, in certain embodiments, the terms "substantially parallel" and "substantially parallel" refer to a value, amount, or characteristic that deviates from exactly parallel by less than or equal to 15 degrees, 10 degrees, 5 degrees, 3 degrees, 1 degree, or 0.1 degrees.

The scope of the present disclosure is not intended to be limited by the particular disclosure of the preferred embodiments in this paragraph or elsewhere in this specification, and may be defined by claims set forth elsewhere in this paragraph or this specification, or in the future. The language of the claims is to be construed broadly based on the language employed in the claims and not limited to examples described in the specification or during the prosecution of the application, which examples are to be construed as non-exclusive.